Skip to main content
. 2015 Apr 13;10(4):e0123140. doi: 10.1371/journal.pone.0123140

Table 1. Hematological, immunologic and biochemistry reference intervals (median and 95th-percentile) stratified by age and gender from a 13–34 years old cohort in rural western Kenya (2003–2005) [15].

Age 13–17 years Age 18–34 years
Parameter Male Female Male Female
RBC (10 6 Cells/μl) 4.9 (4.1–5.8) 4.7 (3.3–5.4) 5.3 (4.3–6.5) 4.5 (3.4–5.7)
Hb (g/dL) 13.1(10.6–15.6) 12.2 (8.1–14.2) 14.2 (11.4–16.9) 12.1 (8.0–14.2)
HCT (%) 38.8 (29.3–48.1) 35.6 (24.8–43.1) 41.7 (32.6–51.5) 35.8 (23.2–44.3)
MCV (fL) 79 (62–92) 78 (57–91) 80 (55–98) 79 (60–94)
PLT (10 3 cells/μl) 224 (103–386) 233 (134–439) 201 (102–307) 220 (88–439)
WBC(10 3 cells/μl) 5.6 (3.3–8.3) 5.2 (3.9–10.2) 5.3 (2.5–7.4) 5.6 (3.3–9.7)
Ne (10 3 cells/μl) 1.9 (0.8–5.0) 2.0 (1.1–3.1) 2.0 (0.8–3.9) 2.3 (1.3–3.8)
Ly (10 3 cells/μl) 2.2 (1.0–4.2) 2.2 (1.1–3.1) 2.2 (1.0–3.5) 2.2 (1.3–3.8)
Mo (10 3 cells/μl) 0.5 (0.2–0.7) 0.4 (0.2–0.7) 0.5 (0.2–0.9) 0.5 (0.3–0.8)
Eo (10 3 cells/μl) 0.4 (0.1–1.8) 0.4 (0.1–2.2) 0.5 (0.1–1.7) 0.4 (0.1–1.3)
Ba (10 3 cells/μl) 0.04 (0.02–0.30) 0.04 (0–0.10) 0.04 (0.01–0.19) 0.04 (0–0.20)
CD4 (10 3 cells/mm 3 ) 874 (367–1571) 934 (465–1553) 811 (462–1306) 866 (440–1602)
CD8(10 3 cells/mm 3 ) 468 (196–988) 505 (195–1068) 486 (201–1104) 472 (262–1167)
CD4% 42 (32–56) 44 (30–56) 41 (29–54) 44 (32–55)
CD8% 23.1(12.4–36.4) 23.5 (17.0–34.8) 24.6 (14.9–44.0) 24.3 (17.5–35.0)
CD4:CD8 ratio 1.8 (1.0–3.1) 1.8 (0.9–3.2) 1.6 (0.8–2.8) 1.8 (0.8–2.8)
ALT (μ/L) 20.5 (4.9–42.4) 17.4 (4.2–65.3) 22.4 (12.0–80.6) 18.9 (10.7–61.3)
AST (μ/L) 26.9 (17.0–59.2) 22.6 (12.0–43.1) 26.7 (12.5–69.3) 22.2 (13.5–48.5)
T-Bil (μmol/L) 13.9 (5.7–62.6) 9.7 (3.7–38.5) 13.8 (5.3–50.7) 11.5 (5.8–36.1)
Creatinine (μmol/L) 66.3 (49.6–103.7) 64.5 (48.0–87.6) 83.1 (54.2–137.8) 70.7 (52.4–96.8)
Glu (mmol/L) 3.8 (2.2–6.6) 3.8 (2.0–7.0) 3.7 (2.1–9.0) 3.8 (2.1–6.0)
BUN (mmol/L) 2.5 (1.7–4.1) 2.3 (1.2–4.8) 3.0 (1.8–5.3) 2.8 (1.4–4.5)